Five studies [34–36, 39, 40] evaluated methylation of the p16 promoter, but none described or discussed the findings in relation to HPV and potential differences between HPV-related and non HPV-related HNSCC. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.